Abbott Laboratories <ABT.N>: Wells Fargo raises target price to $112 from $109
ABT•Related News

Nephros Inc <NEPH.O>: Northland Capital initiates coverage with market perform rating; price target $4
NEPH•

Click Holdings unveils global ESG framework to support international, mainland China expansion
CLIK•

Crown Holdings Inc <CCK.N>: BMO initiates coverage with outperform rating; target price $130
CCK•

UnitedHealth Group <UNH.N>: Deutsche Bank raises target price to $467 from $370
UNH•

ConocoPhillips to buy 42% stake in BP unit tied to Iraq's Kirkuk oilfields
COP•